Netarsudil and latanoprost ophthalmic solution for the reduction of intraocular pressure in open-angle glaucoma or ocular hypertension-Reference-Cited by-同舟云学术

Netarsudil and latanoprost ophthalmic solution for the reduction of intraocular pressure in open-angle glaucoma or ocular hypertension

Published:2019-12-02 Issue:12 Volume:12 Page:1073-1079
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Aref Ahmad A.¹,Geyman Lawrence S.¹,Zakieh Abdel-Rahman²,Alotaibi Humoud M.³

Affiliation:

1. Department of Ophthalmology and Visual Sciences, Illinois Eye & Ear Infirmary, University of Illinois at Chicago College of Medicine, Chicago, IL, USA

2. Chicago Medical School, Rosalind Franklin University, Chicago, IL, USA

3. King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2019.1701435

Reference38 articles.

1. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis

2. Intraocular Pressure, Central Corneal Thickness, and Prevalence of Open-Angle Glaucoma: The Los Angeles Latino Eye Study

3. Baseline Risk Factors that Predict the Development of Open-Angle Glaucoma in a Population

4. Reduction of Intraocular Pressure and Glaucoma Progression

5. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROCK Inhibitors as an Alternative Therapy for Corneal Grafting: A Systematic Review;Journal of Ocular Pharmacology and Therapeutics;2023-11-01

2. COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan®) in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT);Expert Opinion on Drug Safety;2023-09-06

3. Efficacy of Nimodipine Combined with Latanoprost in Treating Open-Angle Glaucoma and Its Influence on Ocular Hemodynamics and Visual Field Defects;Drug Design, Development and Therapy;2022-03